10x Genomics (NASDAQ:TXG – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Friday. Zacks Research cut shares of 10x Genomics from a “strong-buy” rating to a “hold” rating in a research note on Friday, September 5th. Get 10x Genomics alerts:Read Our Latest Stock Report on TXG10x Genomics Stock Performance10x Genomics stock opened at $12.75 on Friday. Insider Buying and SellingIn other 10x Genomics news, CEO Serge Saxonov sold 9,348 shares of 10x Genomics stock in a transaction dated Friday, August 22nd. Featured StoriesReceive News & Ratings for 10x Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 10x Genomics and related companies with MarketBeat.com's FREE daily email newsletter.